Cogent Biosciences (COGT) Other Non-Current Assets (2017 - 2026)

Cogent Biosciences (COGT) has 10 years of Other Non-Current Assets data on file, last reported at $1.9 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 60.1% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.9 million, a 60.1% decrease from a year earlier, with the FY2025 full-year figure at $416000.0, down 91.44% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.9 million, up from $416000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for COGT reached as high as $5.6 million in Q1 2022 and fell as low as $416000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $4.4 million across 5 years, with a median of $4.9 million in 2023.
• Across the five-year window, Other Non-Current Assets jumped 346.69% in 2022 and sank 91.44% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $4.7 million in 2022, then advanced by 2.51% to $4.9 million in 2023, then slipped by 0.04% to $4.9 million in 2024, then sank by 91.44% to $416000.0 in 2025, then surged by 366.35% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.9 million in Q1 2026, $416000.0 in Q4 2025, and $4.5 million in Q3 2025.